Similar articles for PMID: 33813420

Year	Number of Results
1997	1
2003	1
2005	1
2008	2
2009	4
2010	5
2011	5
2012	17
2013	14
2014	15
2015	20
2016	12
2017	13
2018	10
2019	14
2020	16
2021	21
2022	8
2023	0

1

How Much Daily Image-guided Volumetric Modulated Arc Therapy Is Useful for Proctitis Prevention With Respect to Static Intensity Modulated Radiotherapy Supported by Topical Medications Among Localized Prostate Cancer Patients?

Ferini G, Tripoli A, Molino L, Cacciola A, Lillo S, Parisi S, Umina V, Illari SI, Marchese VA, Cravagno IR, Borzì GR, Valenti V. Ferini G, et al. Anticancer Res. 2021 Apr;41(4):2101-2110. doi: 10.21873/anticanres.14981. Anticancer Res. 2021. PMID: 33813420

2

Moderately HRT vs. CRT for localized prostate cancer using image-guided VMAT with SIB: evaluation of acute and late toxicities.

Vassis S, Nöldeke B, Christiansen H, von Klot CA, Merten R. Vassis S, et al. Strahlenther Onkol. 2020 Jul;196(7):598-607. doi: 10.1007/s00066-020-01589-w. Epub 2020 Feb 10. Strahlenther Onkol. 2020. PMID: 32040691 Free PMC article.

3

Whole-pelvic volumetric-modulated arc therapy for high-risk prostate cancer: treatment planning and acute toxicity.

Ishii K, Ogino R, Hosokawa Y, Fujioka C, Okada W, Nakahara R, Kawamorita R, Tada T, Hayashi Y, Nakajima T. Ishii K, et al. J Radiat Res. 2015 Jan;56(1):141-50. doi: 10.1093/jrr/rru086. Epub 2014 Oct 10. J Radiat Res. 2015. PMID: 25304328 Free PMC article. Clinical Trial.

4

Moderately hypofractionated radiotherapy for localized prostate cancer: updated long-term outcome and toxicity analysis.

Tamihardja J, Schortmann M, Lawrenz I, Weick S, Bratengeier K, Flentje M, Guckenberger M, Polat B. Tamihardja J, et al. Strahlenther Onkol. 2021 Feb;197(2):124-132. doi: 10.1007/s00066-020-01678-w. Epub 2020 Aug 24. Strahlenther Onkol. 2021. PMID: 32833036 Free PMC article.

5

Current status of intensity-modulated radiation therapy for prostate cancer: History, clinical results and future directions.

Hatano K, Tohyama N, Kodama T, Okabe N, Sakai M, Konoeda K. Hatano K, et al. Int J Urol. 2019 Aug;26(8):775-784. doi: 10.1111/iju.14011. Epub 2019 May 21. Int J Urol. 2019. PMID: 31115116 Review.

6

Comparison of dosimetric parameters and acute toxicity after whole-pelvic vs prostate-only volumetric-modulated arc therapy with daily image guidance for prostate cancer.

Ishii K, Ogino R, Hosokawa Y, Fujioka C, Okada W, Nakahara R, Kawamorita R, Tada T, Hayashi Y, Nakajima T. Ishii K, et al. Br J Radiol. 2016 Jun;89(1062):20150930. doi: 10.1259/bjr.20150930. Epub 2016 Mar 31. Br J Radiol. 2016. PMID: 26959612 Free PMC article. Clinical Trial.

7

Interfractional Rectal Displacement Requiring Repeated Precaution Did Not Correlate to Biochemical Control and Rectal Toxicity in Patients with Prostate Cancer Treated with Image-guided Intensity-modulated Radiation Therapy.

Iwama K, Yamazaki H, Shimizu D, Suzuki G, Nakamura S, Sasaki N, Takeneka T, Okabe H, Nishikawa T, Yoshida K. Iwama K, et al. Anticancer Res. 2017 Oct;37(10):5755-5760. doi: 10.21873/anticanres.12015. Anticancer Res. 2017. PMID: 28982897

8

Improvement in toxicity in high risk prostate cancer patients treated with image-guided intensity-modulated radiotherapy compared to 3D conformal radiotherapy without daily image guidance.

Sveistrup J, af Rosenschöld PM, Deasy JO, Oh JH, Pommer T, Petersen PM, Engelholm SA. Sveistrup J, et al. Radiat Oncol. 2014 Feb 4;9:44. doi: 10.1186/1748-717X-9-44. Radiat Oncol. 2014. PMID: 24495815 Free PMC article.

9

Hypofractionated Volumetric Modulated Arc Radiotherapy with simultaneous Elective Nodal Irradiation is feasible in prostate cancer patients: A single institution experience.

Hegazy MW, Mahmood RI, Al Otaibi MF, Khalil EM. Hegazy MW, et al. J Egypt Natl Canc Inst. 2016 Jun;28(2):101-10. doi: 10.1016/j.jnci.2016.04.001. Epub 2016 Apr 25. J Egypt Natl Canc Inst. 2016. PMID: 27133975 Free article.

10

Moderate Hypofractionated Postprostatectomy Volumetric Modulated Arc Therapy With Daily Image Guidance (VMAT-IGRT): A Mono-institutional Report on Feasibility and Acute Toxicity.

Fersino S, Tebano U, Mazzola R, Giaj-Levra N, Ricchetti F, Di Paola G, Fiorentino A, Sicignano G, Naccarato S, Ruggieri R, Cavalleri S, Alongi F. Fersino S, et al. Clin Genitourin Cancer. 2017 Aug;15(4):e667-e673. doi: 10.1016/j.clgc.2017.01.025. Epub 2017 Feb 6. Clin Genitourin Cancer. 2017. PMID: 28237181

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed